We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ALNFL market cap is 19.74M. The company's latest EPS is EUR -0.4620 and P/E is -5.26.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 0 | 0 | 0 | 0 | 200k |
| Operating Income | -347k | -318k | -902k | -3.08M | -4.23M |
| Net Income | -267k | -261k | -978k | -2.44M | -3.75M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 467k | 577k | 3.69M | 2.4M | 3.97M |
| Total Liabilities | 56k | 427k | 398k | 1.55M | 3.62M |
| Total Equity | 411k | 150k | 3.29M | 844k | 350k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | N/A | N/A | N/A | N/A | N/A |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 19.74M |
| Price to Earnings Ratio | -5.26 |
| Price to Sales Ratio | 98.38 |
| Price to Cash Ratio | 8.43 |
| Price to Book Ratio | 56.28 |
| Dividend Yield | - |
| Shares Outstanding | 8.11M |
| Average Volume (1 week) | 113.38k |
| Average Volume (1 Month) | 74.65k |
| 52 Week Change | -19.37% |
| 52 Week High | 3.32 |
| 52 Week Low | 0.94 |
| Spread (Intraday) | 0.07 (2.86%) |
| Company Name | NFL Biosciences SA |
| Address |
199 rue helene boucher castelnau-le-lez 34170 |
| Website | https://www.nflbiosciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
